Effect of intravariceal sclerotherapy combined with esophageal mucosal sclerotherapy using small-volume sclerosant for cirrhotic patients with high variceal pressure

doi:10.3748/wjg.v21.i9.2800

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8291)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

457

WORD

333

HTML

3903

Figures (1-2)

457

Tables (1-2)

431

Sum=5581

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1088

Download

1622

Sum=2710

Mar 7, 2015 (publication date) through Nov 3, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Randomized Clinical Trial

World J Gastroenterol. Mar 7, 2015; 21(9): 2800-2806
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2800

Table 1 Demographic profile of the study population

	EVL group(n = 20)	Combined group(n = 18)	P value
Sex			0.208
M	14	9
F	6	9
Age (yr)	53.55 ± 13.72	52.94 ± 14.96	0.897
Child-Pugh grade			0.875
A	9	8
B	11	10
Etiology			1.000
HBV-related	10	10
Alcohol	2	1
PBC	2	2
Cryptogenic	4	4
VP (mmHg)	21.60 ± 3.25	22.04 ± 3.87	0.274
Varix grade			0.612
F₂	10	9
F₃	10	11

VP: Variceal pressure; PBC: Primary biliary cirrhosis; EVL: Endoscopic variceal ligation; HBV: Hepatitis B virus.

Full Size Table

Table 2 Follow-up characteristics

	Combined group(n = 18)	EVL group(n = 20)	P value
Rebleeding	1	3	0.606
Eradication	18	18	0.488
Time to eradication (d)	48.5 ± 21.7	56.1 ± 30.5	0.749
Recurrence	1	7	0.045^a
Mortality	0	0	1.000

^aP < 0.05, combined group vs EVL group, Student’s t test. EVL: Endoscopic variceal ligation.

Full Size Table

Citation: Kong DR, Wang JG, Chen C, Yu FF, Wu Q, Xu JM. Effect of intravariceal sclerotherapy combined with esophageal mucosal sclerotherapy using small-volume sclerosant for cirrhotic patients with high variceal pressure. World J Gastroenterol 2015; 21(9): 2800-2806
URL: https://www.wjgnet.com/1007-9327/full/v21/i9/2800.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i9.2800